Second proof of concept clinical trial of M-281

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 14 Feb 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

07 Feb 2019 According to a Momenta Pharmaceuticals media release, the company now look forward for opening sites and enrolling patients.
04 Oct 2018 According to a Momenta Pharmaceuticals media release, the company will host a live webcast of its R and D day on 11 Oct 2018, which will include a presentation of indications for the planned phase 2 proof of concept studies (this and other 292041).
09 Aug 2018 According to a Momenta Pharmaceuticals media release, this trial is expected to initiate in the fourth quarter of 2018.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com